Literature DB >> 23144047

Prognostic role of persistent positive blood cultures after initiation of antibiotic therapy in left-sided infective endocarditis.

Javier López1, Teresa Sevilla, Isidre Vilacosta, Cristina Sarriá, Ana Revilla, Carlos Ortiz, Carlos Ferrera, Carmen Olmos, Itziar Gómez, José Alberto San Román.   

Abstract

AIM: Persistent infection is not a scientific evidence-based definition. The guidelines of infective endocarditis (IE) establish a cut-off point of 7-10 days, which is arbitrary and probably too long. Our hypothesis is that persistent positive blood cultures after 48-72 h from the initiation of antibiotic therapy are associated with a worse prognosis in patients with left-sided IE. METHODS AND
RESULTS: We repeated blood cultures after 48-72 h of the initiation of the antibiotic treatment in 407 patients with left-sided IE of a total of 692 episodes consecutively diagnosed from 1996 to 2011. We have compared the profile of patients whose blood cultures became negative and those with persistent positive blood cultures. We performed a multivariate logistic regression model to determine the prognostic implication of persistent positive blood cultures. Of 256 patients with positive blood cultures at admission, 89 (35%) had persistent positive cultures after 48-72 h from the initiation of the antibiotic treatment. Persistent positive blood cultures (OR: 2.1; 95% CI: 1.2-3.6), age (OR: 1.026; 95% CI: 1.007-1.046), Staphylococcus aureus infection (OR: 3.3; 95% CI: 1.6-6.6), heart failure (OR: 2.8; 95% CI: 1.6-4.7), and renal failure (OR: 2.9; 95% CI: 1.8-4.9) were found to be independently associated with higher in-hospital mortality.
CONCLUSIONS: The presence of persistent positive blood cultures is an independent risk factor for in-hospital mortality which doubles the risk of death of patients with left-sided IE. It should be taken into account in the risk stratification of these patients.

Entities:  

Keywords:  Blood cultures; Infective endocarditis; Persistent infection; Uncontrolled infection

Mesh:

Substances:

Year:  2012        PMID: 23144047     DOI: 10.1093/eurheartj/ehs379

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  9 in total

1.  My paper 10 years later: infective endocarditis in the intensive care unit.

Authors:  Michel Wolff; Bruno Mourvillier; Romain Sonneville; Jean-François Timsit
Journal:  Intensive Care Med       Date:  2014-09-20       Impact factor: 17.440

Review 2.  [Infective endocarditis : New ESC guidelines 2015].

Authors:  B Plicht; A Lind; R Erbel
Journal:  Internist (Berl)       Date:  2016-07       Impact factor: 0.743

3.  Haemophilus parainfluenzae endocarditis with systemic embolisation following maxillary sinusitis.

Authors:  Margarida Barreto Cortes; Vitor Teixeira; Samuel Raimundo Fernandes; Fernanda Rego
Journal:  BMJ Case Rep       Date:  2016-09-06

4.  Iatrogenic Infective Endocarditis in Hemodialysis Patients: A Case Report and Review of the Literature.

Authors:  Ali Oullaï; Edouard Cubilier; Mohamed Tayeb Salaouatchi; Maxime Taghavi; Yasmin Zouggari; Joëlle Nortier; Maria Do Carmo Filomena Mesquita
Journal:  Case Rep Nephrol       Date:  2022-06-29

Review 5.  Mechanisms of infective endocarditis: pathogen-host interaction and risk states.

Authors:  Karl Werdan; Sebastian Dietz; Bettina Löffler; Silke Niemann; Hasan Bushnaq; Rolf-Edgar Silber; Georg Peters; Ursula Müller-Werdan
Journal:  Nat Rev Cardiol       Date:  2013-11-19       Impact factor: 32.419

6.  Clinical classification and prognosis of isolated right-sided infective endocarditis.

Authors:  Carlos Ortiz; Javier López; Héctor García; Teresa Sevilla; Ana Revilla; Isidre Vilacosta; Cristina Sarriá; Carmen Olmos; Carlos Ferrera; Pablo Elpidio García; Carmen Sáez; Itziar Gómez; José Alberto San Román
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

7.  Daptomycin Plus Fosfomycin Versus Daptomycin Alone for Methicillin-resistant Staphylococcus aureus Bacteremia and Endocarditis: A Randomized Clinical Trial.

Authors:  Miquel Pujol; José-María Miró; Evelyn Shaw; Jose-María Aguado; Rafael San-Juan; Mireia Puig-Asensio; Carles Pigrau; Esther Calbo; Miguel Montejo; Regino Rodriguez-Álvarez; María-Jose Garcia-Pais; Vicente Pintado; Rosa Escudero-Sánchez; Joaquín Lopez-Contreras; Laura Morata; Milagros Montero; Marta Andrés; Juan Pasquau; María-Del-Mar Arenas; Belén Padilla; Javier Murillas; Alfredo Jover-Sáenz; Luis-Eduardo López-Cortes; Graciano García-Pardo; Oriol Gasch; Sebastian Videla; Pilar Hereu; Cristian Tebé; Natalia Pallarès; Mireia Sanllorente; María-Ángeles Domínguez; Jordi Càmara; Anna Ferrer; Ariadna Padullés; Guillermo Cuervo; Jordi Carratalà
Journal:  Clin Infect Dis       Date:  2021-05-04       Impact factor: 9.079

8.  Diagnostic tools in surgically treated patients with infective valve endocarditis.

Authors:  Guenther Kroegh; Khalil Jawad; Piroze Davierwala; Michael Borger; Martin Misfeld
Journal:  Ann Cardiothorac Surg       Date:  2019-11

Review 9.  Early Surgery in Valvular Heart Disease.

Authors:  Dae Hee Kim; Duk Hyun Kang
Journal:  Korean Circ J       Date:  2018-11       Impact factor: 3.243

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.